期刊文献+

^(90)Y标记抗体的双功能络合剂的研究——异硫氰基苄基DTPA与环化DTPA酸酐的比较 被引量:2

STUDY ON THE BIFUNCTIONAL CHELATE AGENTS IN ^(90)Y LABELED ANTIBODY --COMPARSION OF 1-( p- ISOTHIOCYANATO-BENZYL) DTPA AND CYCLIC DTPA ANHYDRIOE
下载PDF
导出
摘要 比较了异硫氰基苄基DTPA(SCN-Bz-DTPA)、环化DTPA酸酐(CDTPA)两种双功能络合剂与单克隆抗体(McAb)的偶联、偶联物与^(90)Y标记和标记物稳定性的差异。结果表明,无论在络合剂对单克隆抗体免疫活性影响方面,还是在标记物稳定性方面,SCN-Bz-DTPA都优于CDTPA。 Two bifunctional chelate agents 1-( p -isothiocyanato-benzyl) DTPA (SCN-Bz-DTPA) and cyclic DTPA anhydride (CDTPA) are synthesized and conjugated with antibody, subsequently labeled with 90Y (Ac)3. There are differences in two chelants conjuated with antibodies and the radiochemical stability of the preparation in Vitro. The results show that SCN-Bz- DTPA is superior to CDTP A.
出处 《核化学与放射化学》 CSCD 北大核心 1993年第4期219-223,共5页 Journal of Nuclear and Radiochemistry
关键词 络合剂 单克隆抗体 放射性标记 Bifunctional chelant Monoclonal antibody Radiolabeling
  • 相关文献

参考文献1

  • 1金小海,同位素,1990年,3卷,3期,161页

同被引文献14

  • 1扶云碧,孟凡义.单克隆抗体在恶性血液病治疗中的应用[J].中华血液学杂志,2005,26(8):509-511. 被引量:1
  • 2Hnatowich DJ, Vrizi F, Doherty PW, et al. DTPA - coupled antibodies labelled with yttrium-90. J Nucl Med. 1985,26:503.
  • 3Sandmaier BM, Bethge WA, Wilbur DS, et al. Bismuth 213 -labelled anti - CD45 radioimmunoconjugate to condition dogs for nonmyeloablatlve allogeneic marrow grafts. Blood. 2002, 100:318.
  • 4Matthews DC, Appelbanm FR, Eary JF, et al. Phase Ⅰ study of ^131I - anti - CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and mydedysplastic syndrome. Blood. 1999,94 : 1237.
  • 5Wagner HN, Wiseman GA, Marcus CS, et al. Administration guidelines for radioimmunotherapy of non - Hodgkin' s lymphoma with ^90y -labelled anti -CD20 monoclonal antibody. J Nucl Med. 2002, 43:267.
  • 6Stimmel JB, Stockstill ME, Kull FC. ^90Y chelation properties of tetraacetic acid macrocycles, diethyle netriamine pentaacetic acid analogues, and a novel terpyridine acyclic chelator. Bioconjug Chem. 1995, 6:219.
  • 7Nemecek ER,Matthews DC.Antibody-based therapy of human leukemia[J].Curr Opin Hematol,2002,9(4):316-21.
  • 8Syrigos KN,Pliarchopoulou K,Harrington KJ.The development of monoclonal antibody therapy in leukemias[J].Hybridoma,2001,20(3):145-8.
  • 9Ruffner KL,Matthews DC.Current uses ofmonoclonal antibodies in the treatment of acute leukemia[J].Semin Oncol,2000,27(5):531-9.
  • 10Sandmaier BM,Bethge WA,Wilbur DS,et al.Bismuth 213-labeled anti-CD45 radioimmunoconjugate to condition dogs for nonmyeloablative allogeneic marrow grafts[J].Blood,2002,100(1):318-26.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部